SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
S-8	Jul 9, 2012	FORM S-8
8-K	Jul 6, 2012	FORM 8-K
S-3	Jul 2, 2012	FORM S-3
4	Jun 19, 2012	PRIMARY DOCUMENT
8-K	Jun 18, 2012	FORM 8-K
POS AM	May 31, 2012	FORM S-3
8-K	May 30, 2012	FORM 8-K
EFFECT	May 29, 2012
424B3	May 25, 2012	PROSPECTUS SUPPLIMENT
RW	May 23, 2012	FORM RW
S-3	May 22, 2012	FORM S-3
8-K/A	May 22, 2012	FORM 8-K/A
424B5	May 16, 2012	FORM 424(B)(5)
10-Q	May 14, 2012	FORM 10-Q
8-K	May 14, 2012	FORM 8-K
RW	May 14, 2012	RW
8-K	May 2, 2012	8-K
DEFA14A	Apr 30, 2012	DEFA14A
DEF 14A	Apr 30, 2012	DEF 14A
424B5	Apr 20, 2012	PROSPECTUS SUPPLEMENT
8-K	Apr 19, 2012	8-K
PRE 14A	Apr 18, 2012	PRELIMINARY PROXY STATEMENT
3	Apr 17, 2012	PRIMARY DOCUMENT
8-K	Apr 16, 2012	FORM 8-K
S-3	Apr 12, 2012	FORM S-3

← Newer Page 37 of 51 · 1272 filings Older →